Development and In vitro kinetic evaluation of PEG-chitosan biohybrid micelles loading CBD with bile acid/quercetin as surface modifiers for colon cancer therapy
Archives of Biochemistry and Biophysics · 2026
DOI: 10.1016/j.abb.2025.110711 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2026. Verfasst von Qurat Ul Ain Haidery und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, PR China. Hauptthemen laut MEDLINE: Quercetin, Chitosan, Micelles, Colonic Neoplasms. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, National Key Research and Development Program of China Stem Cell and Translational Research.
Abstract (Originalsprache)
Treatment for colon cancer is an intricate endeavor that demands innovative strategies for increasing the efficacy while lowering mortality and adverse effects. This study investigates the viability of delivering CBD to colon cancer cells by employing biohybrid micelles for oral delivery. These micelles are made of polyethylene glycol (PEG) and chitosan with bile acid and quercetin on the surface to synergistically increase CBD's anticancer benefits at lower doses and with fewer adverse effects. Chitosan's mucoadhesion and penetration facilitate PEG controlled release. The morphology, crystalline nature, stability, encapsulation efficiency (EE = 77.3 % ± 2 %), and composition of the biohybrid micelles are examined by using SEM, TEM, XRD, HPLC, FTIR, and TGA. IC50 values in μM (HCT116: 9.871 ± 0.244, HT29: 17.110 ± 2.515, Caco-2: 20.023 ± 2.685), colon cancer cell lines showed treatment with these micelles reduced cell survival in a dose-dependent manner relative to free CBD. Apoptosis investigations revealed increased caspase-3/7 activity by biohybrid micelles along with upregulation of Bax expression and downregulation of Bcl-2 expression confirmed by ELISA. Efficiency of component release from biohybrid micelles at varying pH levels is assessed after 72 h at pH 1.2, 6.8, and 7.4 (n ≥ 3). Drug release rates: Bile acid surpasses quercetin, which exceeds CBD (p < 0.05). This innovative drug delivery technique improves CBD colon cancer treatment by combining controlled release with quercetin synergy, laying a foundation for clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, PR China.
- Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, PR China.
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, PR China. Electronic address: maxy@ecust.edu.cn.
- Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, PR China. Electronic address: zwy@ecust.edu.cn.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- National Key Research and Development Program of China Stem Cell and Translational Research
Zitieren
APA
Haidery, Q. U. A., Han, B., Ma, X., & Zheng, W. (2026). Development and In vitro kinetic evaluation of PEG-chitosan biohybrid micelles loading CBD with bile acid/quercetin as surface modifiers for colon cancer therapy. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2025.110711
Vancouver
Haidery QUA, Han B, Ma X, Zheng W. Development and In vitro kinetic evaluation of PEG-chitosan biohybrid micelles loading CBD with bile acid/quercetin as surface modifiers for colon cancer therapy. Archives of Biochemistry and Biophysics. 2026. doi:10.1016/j.abb.2025.110711
BibTeX
@article{Haidery2026,
author = {Haidery, Qurat Ul Ain and Han, Bo and Ma, Xingyuan and Zheng, Wenyun},
title = {Development and In vitro kinetic evaluation of PEG-chitosan biohybrid micelles loading CBD with bile acid/quercetin as surface modifiers for colon cancer therapy},
journal = {Archives of Biochemistry and Biophysics},
year = {2026},
doi = {10.1016/j.abb.2025.110711}
}
EUVIMED